Related Experiment Video
Updated: Jun 15, 2026
08:04
Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes
1Service Endocrinologie, Diabétologie et Maladies Métaboliques, Dijon University Hospital, France. bruno.verges@chu-dijon.fr
Atherosclerosis
|March 2, 2010
Summary
Type 2 diabetes increases Very Low Density Lipoprotein (VLDL) production, leading to harmful lipid changes. Insulin resistance and other factors drive this detrimental VLDL overproduction in diabetic dyslipidemia.
Area of Science:
- Endocrinology
- Metabolic Syndrome
- Lipid Metabolism
Background:
- Diabetic dyslipidemia is characterized by increased Very Low Density Lipoprotein (VLDL) production.
- This VLDL overproduction contributes to atherogenic remnants, small dense Low Density Lipoprotein (LDL) particles, and triglyceride-rich High Density Lipoprotein (HDL) particles.
Purpose of the Study:
- To elucidate the pathophysiological factors contributing to increased VLDL production in type 2 diabetes.
Main Methods:
- The study reviews existing literature on the molecular mechanisms underlying VLDL overproduction in type 2 diabetes.
- Focuses on the roles of insulin resistance, de novo lipogenesis, and adiponectin.
Main Results:
- Insulin resistance impairs PI3-kinase activation, reduces apoB degradation, and increases MTP expression, promoting VLDL(1) formation.
- Peripheral insulin resistance increases adipose tissue lipolysis, augmenting FFA flux to the liver and stimulating VLDL production.
- Increased de novo lipogenesis via SREBP-1c and ChREBP activation, alongside decreased adiponectin, further exacerbates VLDL overproduction.
Conclusions:
- Insulin resistance, impaired lipolysis, enhanced de novo lipogenesis, and reduced adiponectin are key drivers of increased VLDL production in type 2 diabetes.
- Understanding these mechanisms is crucial for managing diabetic dyslipidemia and reducing cardiovascular risk.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...